Ainos, Inc. (NASDAQ:AIMDW) Sees Significant Decrease in Short Interest

Ainos, Inc. (NASDAQ:AIMDW) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 3,832 shares, a drop of 25.4% from the December 15th total of 5,136 shares. Based on an average daily volume of 675 shares, the short-interest ratio is presently 5.7 days. Based on an average daily volume of 675 shares, the short-interest ratio is presently 5.7 days.

Ainos Stock Up 13.8%

Ainos stock opened at $0.10 on Friday. Ainos has a 1-year low of $0.05 and a 1-year high of $0.95. The company has a fifty day simple moving average of $0.11 and a 200 day simple moving average of $0.18.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.